- Federal funding cuts to HIV prevention programs from 2017 to 2020 led to an 18% drop in access to lifesaving services.
- New HIV infections plateaued during this period, with sharp increases among young Black and Latino men.
- Clinic closures, reduced testing outreach, and limited access to PrEP affected over 30 states, especially in the South.
- The funding cuts reversed a decade-long trend of expanding care and prevention in high-risk communities.
- Public health experts had long warned that redirecting resources from targeted prevention efforts would undermine progress.
In the wake of federal funding cuts to HIV prevention programs between 2017 and 2020, access to lifesaving services dropped by 18%, according to recently released data from the U.S. Centers for Disease Control and Prevention (CDC). This decline marks the first significant reversal in a decade-long trend of expanding care and prevention across high-risk communities. New infections, which had fallen steadily since 2010, plateaued during this period, with particularly sharp increases among young Black and Latino men. The data confirms long-held fears among public health experts that redirecting resources from targeted prevention efforts would undermine progress. Clinic closures, reduced testing outreach, and diminished access to pre-exposure prophylaxis (PrEP) were reported in over 30 states, especially in the South, where HIV rates are highest.
Why the Cuts Stalled a Decade of Progress
For years, the U.S. had been on track to end the HIV epidemic by 2030, a goal first articulated under the Obama administration and initially embraced by its successor. Between 2010 and 2016, new HIV diagnoses dropped by 11% nationally, driven by expanded testing, early treatment, and widespread rollout of PrEP. However, starting in 2017, the Trump administration redirected funds from community-based HIV prevention programs toward broader initiatives focused on abstinence and opioid control—policies critics argued were ideologically driven rather than evidence-based. The shift affected key programs like the CDC’s High-Impact Prevention portfolio and the Ryan White HIV/AIDS Program, which supports care for low-income patients. By 2019, the rate of new diagnoses stopped declining, and in some demographics, began to rise—a trend not seen since the early 2000s.
What the Data Shows About Service Access
The latest CDC surveillance report, finalized in early 2024, provides a comprehensive picture of how funding reallocations impacted service delivery. Between 2017 and 2020, the number of individuals receiving free HIV testing through federally funded clinics fell by 22%, while PrEP prescriptions in public health systems dropped by 15%. In states like Texas and Florida, mobile testing units were eliminated, and community health workers were laid off. The impact was most severe in rural areas and among marginalized populations, including transgender individuals and people who inject drugs. Notably, the South, which accounts for over half of all new HIV cases in the U.S., saw the largest funding reductions. The CDC report acknowledges that these service disruptions coincided with a 7% increase in new diagnoses among men who have sex with men aged 13–29, a demographic that had previously shown the most improvement.
Policy Shifts and Their Unintended Consequences
Analysis of budget documents and program audits reveals that the Trump administration redirected approximately $70 million from targeted HIV prevention to abstinence-only education and faith-based outreach programs with no proven efficacy in reducing transmission rates. A 2021 study published in The Lancet HIV estimated that every $1 cut from PrEP access resulted in 2.3 additional HIV infections over five years. Experts argue that the administration prioritized moralistic policy goals over data-driven public health strategy. The Department of Health and Human Services (HHS) also imposed new reporting requirements on grantees, slowing disbursement and discouraging smaller organizations from applying. According to Dr. Harold Phillips, who later served as the White House National HIV/AIDS Policy Advisor, these changes created a “chilling effect” on local programs just as new tools like long-acting injectable PrEP were becoming available.
Who Was Hit Hardest by the Rollback
The consequences of reduced funding fell disproportionately on already vulnerable communities. Black Americans, who make up 13% of the U.S. population, accounted for 42% of new HIV diagnoses in 2020, up from 40% in 2016. Latino men saw a 10% rise in new infections during the same period. Transgender women, particularly those of color, faced growing barriers to care due to clinic closures and stigma-informed policy changes. Rural residents, especially in the Deep South, lost access to the only HIV specialists within hundreds of miles. The rollback also delayed the implementation of the Ending the HIV Epidemic (EHE) initiative, which was officially launched in 2019 but underfunded in its first two years. As a result, only 28% of the 57 priority counties identified by EHE received full program support by 2020.
Expert Perspectives
Public health leaders remain divided on how to interpret the data. Dr. Demetre Daskalakis of the CDC called the funding cuts “a self-inflicted setback” that delayed epidemic control by at least five years. Others, like Dr. Robert Redfield, former CDC director under Trump, argue that the administration maintained overall HIV spending and later restored key programs. However, independent analysts from KFF (Kaiser Family Foundation) note that reallocation—not total spending—is what mattered most. “It’s not just about the dollar amount,” said Jennifer Kates, director of global health and HIV policy. “It’s about whether the money reaches the people most at risk.”
As the Biden administration works to revive the EHE initiative with increased funding and equity-focused strategies, questions remain about long-term recovery. Can trust be restored in communities that lost services? Will new technologies like injectable PrEP and at-home testing kits close the gap? With federal funding now restored and expanded, the next three years will be critical in determining whether the U.S. can regain lost ground and stay on track to end the HIV epidemic by 2030.
Source: Vox